Cite
MLA Citation
A. Zelenetz et al.. “S208: EFFICACY AND SAFETY OF ZANDELISIB ADMINISTERED BY INTERMITTENT DOSING (ID) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF THE GLOBAL PHASE 2 STUDY TIDAL.” HemaSphere, vol. 6, n.d., pp. 109–110. http://access.bl.uk/ark:/81055/vdc_100158013494.0x000009